Literature DB >> 16475613

TP53 mutations in salivary gland neoplasms.

Luciana Fasanella Matizonkas-Antonio1, Ricardo Alves de Mesquita, Suzana C Orsini Machado de Souza, Fabio Daumas Nunes.   

Abstract

Many studies have demonstrated that loss of TP53 gene function has an important role in the genesis of many neoplasms, including salivary gland neoplasms. The purpose of this study was to examine the mutation profile of the TP53 gene in salivary gland neoplasms. Genomic DNA was extracted from paraffin-embedded tissues of pleomorphic adenoma, carcinoma in pleomorphic adenoma, mucoepidermoid carcinoma, adenoid cystic carcinoma and polymorphous low grade adenocarcinoma. Exons 5 to 8 of the TP53 gene were amplified by polymerase chain reaction (PCR) to perform single-stranded conformational polymorphism (SSCP) analysis. Band shifting was observed in exons 5, 6 and 8 in 9 out of 18 neoplasms. The results of this study suggest that mutations in TP53 gene are related to salivary gland neoplasms pathogenesis and that exons 5 and 8 are most frequently involved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16475613     DOI: 10.1590/s0103-64402005000200014

Source DB:  PubMed          Journal:  Braz Dent J        ISSN: 0103-6440


  7 in total

Review 1.  p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy.

Authors:  Christie Rodriguez-Ramirez; Jacques E Nör
Journal:  Crit Rev Oncog       Date:  2018

2.  P53 mutation is a rare event in Merkel cell carcinoma of the head and neck.

Authors:  Claudia Lill; Sven Schneider; Chike B Item; Robert Loewe; Roland Houben; Daniel Halbauer; Gregor Heiduschka; Markus Brunner; Dietmar Thurnher
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-18       Impact factor: 2.503

3.  Whole-Exome Sequencing of Salivary Gland Mucoepidermoid Carcinoma.

Authors:  Hyunseok Kang; Marietta Tan; Justin A Bishop; Siân Jones; Mark Sausen; Patrick K Ha; Nishant Agrawal
Journal:  Clin Cancer Res       Date:  2016-06-23       Impact factor: 12.531

4.  Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma.

Authors:  Kristy A Warner; Felipe Nör; Gerson A Acasigua; Manoela D Martins; Zhaocheng Zhang; Scott A McLean; Matthew E Spector; Douglas B Chepeha; Joseph Helman; Michael J Wick; Christopher A Moskaluk; Rogerio M Castilho; Alexander T Pearson; Shaomeng Wang; Jacques E Nör
Journal:  Clin Cancer Res       Date:  2016-03-02       Impact factor: 12.531

5.  Breast- and salivary gland-derived adenoid cystic carcinomas: potential post-transcriptional divergencies. A pilot study based on miRNA expression profiling of four cases and review of the potential relevance of the findings.

Authors:  Orsolya Kiss; Anna-Mária Tőkés; Sándor Spisák; Anna Szilágyi; Norbert Lippai; Borbála Székely; A Marcell Szász; Janina Kulka
Journal:  Pathol Oncol Res       Date:  2014-09-21       Impact factor: 3.201

6.  Assessment of TP53 mutations in benign and malignant salivary gland neoplasms.

Authors:  Carolina Cavaliéri Gomes; Marina Gonçalves Diniz; Lissur Azevedo Orsine; Alessandra Pires Duarte; Thiago Fonseca-Silva; Brendan I Conn; Luiz De Marco; Cláudia Maria Pereira; Ricardo Santiago Gomez
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

7.  Image cytometric analysis of p53 and mdm-2 expression in primary and recurrent mucoepidermoid carcinoma of parotid gland: immunohistochemical study.

Authors:  Ehab S Abd-Elhamid; Mohamed H Elmalahy
Journal:  Diagn Pathol       Date:  2010-11-22       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.